Strattera and Herpes zoster - a phase IV clinical study of FDA data

Summary:

Herpes zoster is reported as a side effect among people who take Strattera (atomoxetine hydrochloride), especially for people who are female, 40-49 old, have been taking the drug for 6 - 12 months also take Bactrim, and have Humoral immune defect.

The phase IV clinical study analyzes which people have Herpes zoster when taking Strattera. It is created by eHealthMe based on reports of 27,428 people who have side effects when taking Strattera from the FDA, and is updated regularly.

What is Strattera?

Strattera has active ingredients of atomoxetine hydrochloride. It is often used in attention deficit hyperactivity disorder. eHealthMe is studying from 29,323 Strattera users. Check the latest studies of Strattera.

What is Herpes zoster?

Herpes zoster is found to be associated with 1,824 drugs and 2,167 conditions by eHealthMe. Check the latest studies of Herpes zoster.

On Jul, 18, 2026

27,428 people reported to have side effects when taking Strattera.
Among them, 29 people (0.11%) have Herpes zoster.

Among these 29 people:

How long have people been on Strattera when they have Herpes zoster? *

What is the gender of people who have Herpes zoster when taking Strattera? *

female: 55.56 %
male: 44.44 %

What is the age of people who have Herpes zoster when taking Strattera? *

What are other drugs people take besides Strattera? *

What are other side effects people have besides Herpes zoster? *

Headache (pain in head): 14 people, 48.28%
Rashes (redness): 12 people, 41.38%
Fatigue (feeling of tiredness): 11 people, 37.93%
Peripheral Swelling: 10 people, 34.48%
Nausea And Vomiting: 9 people, 31.03%
Fever: 9 people, 31.03%
Sinusitis (inflammation of sinus): 8 people, 27.59%
Gastroenteritis Viral (inflammation of stomach and intestine caused by virus infection): 8 people, 27.59%
Pain: 8 people, 27.59%
The Flu (the flu is caused by an influenza virus): 8 people, 27.59%

What are the existing conditions these people have? *

Bipolar I Disorder (mood disorder that is characterized by at least one manic or mixed episode): 3 people, 10.34%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 3 people, 10.34%
Immunodeficiency Common Variable: 3 people, 10.34%
Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 3 people, 10.34%
Humoral Immune Defect (impairment of humoral immunity): 3 people, 10.34%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 6.90%
Stress And Anxiety: 1 person, 3.45%
Growth Hormone Deficiency: 1 person, 3.45%
Back Pain: 1 person, 3.45%
Chronic Thyroiditis (long lasting inflammation of thyroid gland): 1 person, 3.45%

* Approximation only. Some reports may have incomplete information.

Do you take Strattera and have Herpes zoster?

- Check whether Herpes zoster is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Strattera:

Strattera (29,323 reports)

Herpes zoster treatments and more:

Herpes zoster (88,626 reports)

Browse all side effects of Strattera:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Herpes zoster:

Herpes zoster (1,824 drugs)

Browse all the conditions that are associated with Herpes zoster:

Herpes zoster (2,167 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on atomoxetine hydrochloride (the active ingredients of Strattera) and Strattera (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.